Global Longlife Peer Comparison
BSE: 543520
₹13.39
₹0.63
(4.94%)
As on 08-Sep-2026IST
Market cap
₹14 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
0 %
Edit
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
14 | 228 | 100 | 39 | 30 |
Revenue (₹ Cr) |
-- | 57 | 26 | 17 | 24 |
Net Profit (₹ Cr) |
-1.72 | 0.15 | -0.45 | 1.93 | -3.62 |
Net Margin (%) |
-33,067.31 | 0.26 | -1.72 | 10.69 | -15.36 |
RoE (%) |
-7.22 | 0.26 | -3.41 | 5.30 | -- |
Price to Earnings |
-- | 1,520.90 | -- | 20.06 | -- |
Price-To-Book |
0.62 | 3.76 | 8.17 | 1.14 | -11.34 |
Income Statement (₹ Cr)
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | -- | -- | -- | -- |
|
Total Income
|
0.01 | -- | -- | -- | -- |
|
Total Expenditure
|
0.99 | -- | -- | -- | -- |
|
EBITDA
|
-0.99 | -- | -- | -- | -- |
|
Depreciation
|
-- | -- | -- | -- | -- |
|
EBIT
|
-0.99 | -- | -- | -- | -- |
|
Interest
|
0.00 | -- | -- | -- | -- |
|
Other Income
|
0.01 | -- | -- | -- | -- |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-0.99 | -- | -- | -- | -- |
|
Provision for Tax
|
0.73 | -- | -- | -- | -- |
|
Profit after Tax
|
-1.72 | -- | -- | -- | -- |
Liabilities (₹ Cr)
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
23.75 | -- | -- | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
-2.35 | -- | -- | -- | -- |
|
Current Liabilities
|
0.01 | -- | -- | -- | -- |
|
Total Liabilities
|
23.76 | -- | -- | -- | -- |
Assets (₹ Cr)
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.01 | -- | -- | -- | -- |
|
Current Assets
|
20.29 | -- | -- | -- | -- |
|
Total Assets
|
23.76 | -- | -- | -- | -- |
|
Total Debt*
|
0.00 | -- | -- | -- | -- |
|
Net Current Assets
|
20.28 | -- | -- | -- | -- |
|
Contingent Liabilities
|
-- | -- | -- | -- | -- |
Cashflow (₹ Cr)
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-4.51 | -- | -- | -- | -- |
|
Cash Flow from Investing Activities
|
0.04 | -- | -- | -- | -- |
|
Cash from Financing Activities
|
0.00 | -- | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-4.47 | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-4.15 | -- | -- | -- | -- |
|
ROE (%)
|
-7.22 | -- | -- | -- | -- |
|
ROA (%)
|
-7.49 | -- | -- | -- | -- |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-33,067.31 | -- | -- | -- | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-100.00 | -- | -- | -- | -- |
|
EBIT Growth (%)
|
-212.69 | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-965.37 | -- | -- | -- | -- |
|
EPS Growth (%)
|
-965.54 | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-9.33 | -- | -- | -- | -- |
Valuation Ratios
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | -- | -- | -- | -- |
|
Price / Book Value
|
0.63 | -- | -- | -- | -- |
|
Dividend Yield (%)
|
0.00 | -- | -- | -- | -- |
|
EV/EBITDA
|
2.71 | -- | -- | -- | -- |
|
Market Cap (₹ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -- | -- | -- | -- |
|
Short term debt to equity ratio
|
-- | -- | -- | -- | -- |
|
Current Ratio
|
1,691.15 | -- | -- | -- | -- |
|
Quick Ratio
|
1,691.15 | -- | -- | -- | -- |
|
Interest Coverage
|
-3,292.33 | -- | -- | -- | -- |
Operating Efficiency Ratios
| Global Longlife | Lotus Eye Hosp | Aspira Pathlab | NG | Soni Medicare | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | -- | -- | -- | -- |
|
Asset Turnover
|
0.00 | -- | -- | -- | -- |
|
Receivable days
|
-- | -- | -- | -- | -- |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
-- | -- | -- | -- | -- |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
